Published in JAMA on May 04, 1992
Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging (2002) 2.64
Prostate-specific antigen. Improving its ability to diagnose early prostate cancer. JAMA (1992) 2.38
Screening for ovarian, prostatic, and testicular cancers. BMJ (1994) 1.80
Prostate-specific antigen-based screening: controversy and guidelines. BMC Med (2015) 1.08
Screening for cancer. Is it worth it? West J Med (1995) 1.07
PSA testing: are patients aware of what lies ahead? Ann R Coll Surg Engl (2006) 1.05
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer (1994) 1.04
A focus group study of factors influencing African-American men's prostate cancer screening behavior. J Natl Med Assoc (2004) 1.04
Radical prostatectomy: lower rates among African-American men. J Natl Med Assoc (1996) 1.03
The dilemma of hereditary prostate cancer. CMAJ (1995) 0.89
Selecting candidates for radical prostatectomy. Rev Urol (2000) 0.89
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients. Br J Cancer (1999) 0.88
Expectant management as an option for men with stage T1c prostate cancer: a preliminary study. World J Urol (1997) 0.87
Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits. CMAJ (1996) 0.84
Regaining candidacy for heart transplantation after robotic assisted laparoscopic radical prostatectomy in left ventricular assist device patient. Case Rep Transplant (2012) 0.84
Patient preferences for management of localized prostate cancer. West J Med (1996) 0.83
Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy. Br J Cancer (1996) 0.83
Complications and functional results of surgery for locally advanced prostate cancer. Adv Urol (2012) 0.83
What urologists say they do for men with prostate cancer. BMJ (1999) 0.80
An audit of the investigation and treatment of localised prostatic cancer in the south west region. Ann R Coll Surg Engl (1999) 0.80
Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience. Rev Urol (2001) 0.77
Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH. Br J Cancer (1994) 0.77
Cancer of the prostate. JAMA (1992) 0.75
Cancer of the prostate. JAMA (1992) 0.75
Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans. J Natl Med Assoc (1997) 0.75
Screening for prostatic cancer. BMJ (1993) 0.75
Prostate Cancer - What's New? Med J Armed Forces India (2011) 0.75
Cancer of the prostate. JAMA (1992) 0.75
What is the risk posed by prostate cancer? J Natl Cancer Inst Monogr (2012) 0.75
Localized prostate cancer: early intervention or expectant therapy? J R Soc Med (1997) 0.75
Cancer of the prostate. JAMA (1992) 0.75
Watchful waiting for localized prostate cancer. West J Med (1994) 0.75
Surgical therapy for localized prostatic carcinoma. J Cancer Res Clin Oncol (1997) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med (1980) 4.03
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Stressful life events and Graves' disease. Lancet (1991) 3.63
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am (2000) 3.18
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30
The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology (1997) 2.29
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol (2002) 2.09
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial. Eur J Cancer (2006) 2.09
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med (1985) 2.02
[Meta-analysis is a good help for literature review. It makes the analysis of earlier studies more efficient and more objective]. Lakartidningen (1999) 2.02
Pesticides and cancer. Cancer Causes Control (1997) 2.00
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
[Problems of interpretation in vascular surgery]. Lakartidningen (1993) 1.94
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90
Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst (1993) 1.87
Observed and relative survival after aortic valve replacement. J Am Coll Cardiol (2000) 1.86
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (2006) 1.84
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82